Actively Recruiting
Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
Led by Kaplan Medical Center · Updated on 2025-04-06
1000
Participants Needed
1
Research Sites
168 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be collected to correlate phenotype with absolute neutrophil count (ANC).
CONDITIONS
Official Title
Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025
- Parental informed consent obtained
- Umbilical cord blood available for routine testing
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kaplan Medical Center
Rehovot, Israel, Israel, 7661041
Actively Recruiting
Research Team
T
Tal Ben Ami, M.D
CONTACT
Y
Yael Zeitak, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here